Endpoint and definitions | Data source |
Mortality outcomes | |
Inpatient mortality | Hospital record |
Dialysis outcomes | |
Inpatient dialysis | Order entry system |
Discharged on dialysis | Social work records |
Renal failure outcomes | |
Percent who progress to Stage 2 AKI | Laboratory values |
Percent who progress to Stage 3 AKI | Laboratory values |
Duration of AKI | Laboratory values |
Readmission rate and costs | |
30-day readmission rate | Hospital record |
Cost of index hospitalisation | Billing records |
Individual ‘Best Practice’ outcomes (proportion achieved per patient in study arm during index hospitalisation) | |
Contrast administration | Order entry system |
Fluid administration | Order entry system |
Aminoglycoside administration | Order entry system |
NSAID administration/cessation | Order entry system |
ACE inhibitor administration/cessation | Order entry system |
Urinalysis order | Order entry system |
Documentation of AKI | Postdischarge ICD-10 codes |
Monitoring of creatinine | Order entry system |
Monitoring of urine output | Hospital Record |
Renal consult | Direct chart review |
Provider awareness outcomes | |
Chart documentation of AKI (by post discharge ICD-10 codes) | Billing records |
Chart documentation of AKI (adjudicated) | Direct chart review |
ACE, angiotensin converting enzyme; AKI, acute kidney injury; NSAID, non-steroidal anti-inflammatory drug.